PACB Report

Pacific Biosciences of California, Inc.
Stock Exchange: NASDAQ
Sector: healthcare
9.9
Last session price
9.9
Price now
Currency: USD
Reporting currency: USD
ISIN: US69404D1081
INN:
.

PACB financial statements

* Numbers in millions
Year
 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 TTM
Capitalization *
 232 142 459 567 808 426 305 919 715 5 344 1 635
EV *
 173 95 446 544 790 425 303 914 717 5 079 5 079
Stock price $
 4.31 2.54 7.31 8.04 10.69 4.78 2.89 6.8 4.69 32.35 9.9
Number of shares *
 54 56 63 70 76 89 106 135 153 165 165
EPS
 -2,03 -1,69 -1,26 -0,94 -0,42 -0,83 -0,87 -0,76 -0,55 0,18 0,18
Revenue *
 34 26 28 61 93 91 93 79 91 79 79
Net income *
 -109 -94 -79 -66 -32 -74 -92 -103 -84 29 29
Operating profit *
 -110 -94 -78 -63 -52 -71 -90 -101 -101 -104 -104
Total liabilities *
 27 20 67 70 58 53 58 56 93 78 78
Net debt *
 -56 -44 73 43 30 55 43 79 2 -265 -265
Total assets *
 218 130 136 125 131 138 144 170 148 414 414
Equity *
 191 109 69 55 74 85 86 114 55 335 335
Cash and investments *
 177 101 113 101 82 72 63 102 49 556 556

Over the past 10 years, the maximum capitalization of Pacific Biosciences of California, Inc. is 5 344, the minimum is 142.
Maximum net income 29, Minimum net income -109.
The maximum price of PACB shares is 32.35, the minimum price is 2.54.

.

PACB valuation

Year
 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 TTM
P/E
 -2,12 -1,50 -5,79 -8,56 -25,50 -5,73 -3,31 -8,96 -8,50 181,74 55,62
P/B
 1,21 1,29 6,63 10,31 10,99 5,03 3,55 8,05 13,03 15,93 4,87
P/S
 6,86 5,45 16,29 9,35 8,71 4,70 3,27 11,68 7,87 67,73 20,73
E/P
 -47% -67% -17% -12% -4% -17% -30% -11% -12% 1% 2%
P/FCF
 -2,07 -1,80 -14,93 -10,68 -15,88 -5,60 -3,92 -13,45 -8,82 289,42 88,57
.

PACB profitability

Year
 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 TTM
ROE
 -57% -86% -115% -120% -43% -88% -107% -90% -153% 9%
ROA
 -50% -73% -58% -53% -24% -54% -64% -60% -57% 7%
ROIC
 -55% -82% -68% -68% -56% -68% -78% -70% -102% -28%